Neutrophil Prealbumin Ratio as a Potential Predictive Marker for Severe Burn Patients’ Prognosis
Journal of Burn Care & Research · 2025
DOI: 10.1093/jbcr/iraf096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Burn Care & Research, 2025. Verfasst von Ozan Baris Namdaroglu und 7 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, University of Health Sciences Tepecik Education and Research Hospital, Izmir, Turkey. Hauptthemen laut MEDLINE: Neutrophils, Prealbumin, Burns. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objective
Severe burn injuries are associated with high morbidity and mortality, necessitating reliable prognostic markers for effective patient management. The Neutrophil-to-Prealbumin Ratio (NPR), which combines inflammatory and nutritional status, has emerged as a potential prognostic tool. This study aimed to evaluate the prognostic value of NPR in predicting mortality among severe burn patients.
Design
Patients were categorized into survivor and nonsurvivor groups.
Setting
The study was conducted retrospectively.
Participants
Severe burn patients admitted to the Burn Treatment Center between January 2020 and December 2023 were analyzed. Main Outcomes Inflammatory markers, including NPR, Neutrophil-to-Lymphocyte Ratio, Systemic Inflammatory Response Index, and Platelet-to-Lymphocyte Ratio, were evaluated for their association with mortality using Receiver Operating Characteristic curve analysis and multivariate logistic regression.
Results
A total of 357 patients were included in the study. Of the 357 patients, 101 (28.3%) were nonsurvivors. The nonsurvivor group had significantly higher TBSA, full-thickness burns, inhalation injuries, and blood transfusion requirements (P < .001). Receiver Operating Characteristic curve analysis demonstrated that NPR had the highest area under the curve (0.760). A cut-off value of 0.75 for NPR was associated with a significant increase in mortality risk. Multivariate logistic-regression analysis identified NPR as an independent predictor of mortality alongside TBSA, full-thickness burns, and inhalation injuries. Conclusions and Relevance Neutrophil-to-Prealbumin Ratio is a promising prognostic marker for mortality in severe burn patients, outperforming traditional inflammatory markers. Its integration of inflammatory and nutritional status provides a comprehensive assessment of patient risk. Further prospective studies are needed to validate these findings and explore the broader applications of NPR in burn care and other critical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery Department, University of Health Sciences Tepecik Education and Research Hospital, Izmir, Turkey.
- General Surgery Department, Marmara University Pendik Research and Training Hospital, Istanbul, Turkey.
- Surgical Oncology Department, Antalya City Hospital, Antalya, Turkey.
- Burn Treatment Center, Izmir City Hospital, Izmir Turkey.
ORCID-Profile: Hilmi Yazıcı
Zitieren
APA
Namdaroglu, O. B., Yazıcı, H., Esmer, A. C., Ugur, M. A., Erdogan, A. E., Ozturk, A. M., Ucar, A. D., & Yildirim, M. (2025). Neutrophil Prealbumin Ratio as a Potential Predictive Marker for Severe Burn Patients’ Prognosis. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/iraf096
Vancouver
Namdaroglu OB, Yazıcı H, Esmer AC, Ugur MA, Erdogan AE, Ozturk AM, et al. Neutrophil Prealbumin Ratio as a Potential Predictive Marker for Severe Burn Patients’ Prognosis. Journal of Burn Care & Research. 2025. doi:10.1093/jbcr/iraf096
BibTeX
@article{Namdaroglu2025,
author = {Namdaroglu, Ozan Baris and Yazıcı, Hilmi and Esmer, Ahmet Cem and Ugur, Mehmet Alperen and Erdogan, Ahmet Erim and Ozturk, Ahmet Mucteba and Ucar, Ahmet Deniz and Yildirim, Mehmet},
title = {Neutrophil Prealbumin Ratio as a Potential Predictive Marker for Severe Burn Patients’ Prognosis},
journal = {Journal of Burn Care & Research},
year = {2025},
doi = {10.1093/jbcr/iraf096}
}
EUVIMED